FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically a heterocyclic compound of general formula I or a stereoisomer thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen or halogen atom and R11 represents a hydrogen atom or a hydroxy group. Invention also relates to a method for differentiating stem cells into hepatocytes.
.
EFFECT: technical result: novel heterocyclic compounds are obtained for use as platforms for drug screening and for use in modeling diseases.
27 cl, 18 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
| SUBSTITUTED 3-OXO-1,2,3,4-TETRAHYDROXINOXALINES, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHODS FOR PRODUCTION AND USES THEREOF | 2003 |
|
RU2251546C1 |
| PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
| COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR | 2016 |
|
RU2718917C2 |
| DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
| MEDICINAL AGENTS FOR TREATMENT OF MALIGNANT TUMORS | 2000 |
|
RU2240313C2 |
| HERBICIDE AGENT BASED ON ARYLSULFONYLAMINOCARBONYLTRIAZOLINONES | 1997 |
|
RU2240691C2 |
| LOW-MOLECULAR WEIGHT Trp-p8 ACTIVITY MODULATORS | 2007 |
|
RU2509079C2 |
| ADAMANTYL DERIVATIVES USEFUL FOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2626890C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR | 2005 |
|
RU2388476C2 |
